Article info
PDFTherapeutics
Systematic review and meta analysis
Intensive glucose-lowering therapy in people with type 2 diabetes: what do we learn from a new meta-analysis of randomised controlled trials?
- Correspondence to Fiona Turnbull
Cardiovascular Division, The George Institute for Global Health, Level 10, KGV Building, RPAH, Missenden Rd, Camperdown, New South Wales 2050, Australia; fturnbull{at}george.org.uk
Citation
Intensive glucose-lowering therapy in people with type 2 diabetes: what do we learn from a new meta-analysis of randomised controlled trials?
Publication history
- First published November 28, 2011.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions